We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Sierra Oncology Inc | NASDAQ:SRRA | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 54.99 | 54.99 | 45.10 | 0 | 01:00:00 |
CUSIP No. 82640U107
|
Page 2 of 10
|
1
|
NAMES OF REPORTING PERSONS
|
|
|
||
THE MANGROVE PARTNERS MASTER FUND, LTD. |
|
|
|||
|
|
||||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
||||
(a)☒
|
|||||
(b)☐
|
|
|
|||
3
|
SEC USE ONLY
|
|
|
||
|
|
|
|||
|
|
||||
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|
||
CAYMAN ISLANDS
|
|
|
|||
|
|
||||
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
|
5
|
SOLE VOTING POWER
|
|
|
|
0
|
|
|
|||
|
|
||||
6
|
SHARED VOTING POWER
|
|
|
||
587,464 (1)
|
|
|
|||
|
|
||||
7
|
SOLE DISPOSITIVE POWER
|
|
|
||
0
|
|
|
|||
|
|
||||
8
|
SHARED DISPOSITIVE POWER
|
|
|
||
587,464 (1)
|
|
|
|||
|
|
||||
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|
|
||
587,464 (1)
|
|
|
|||
|
|
||||
10
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
|
|
|
||
☐
|
|
|
|||
|
|
||||
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
|
|
|
||
5.1% (2) |
|
|
|||
|
|
||||
12
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
|
|
|
||
OO |
|
|
|||
|
|
|
(1) |
Includes 359,812 Shares obtainable upon exercise of Series A Warrants and 118,738 Shares obtainable upon exercise of Series B Warrants.
|
|
(2) |
This percentage is calculated based on the sum of (i) 11,040,600 Shares outstanding as of November 2, 2020 according to the Issuer’s Form 10-Q, filed on November 5, 2020, (ii) 359,812 Shares obtainable upon exercise
of Series A Warrants and (iii) 118,738 Shares obtainable upon exercise of Series B Warrants.
|
CUSIP No. 82640U107
|
Page 3 of 10
|
1
|
NAMES OF REPORTING PERSONS
|
|
|
||
MANGROVE PARTNERS
|
|
|
|||
|
|
||||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
||||
(a)☒
|
|||||
(b)☐
|
|
|
|||
3
|
SEC USE ONLY
|
|
|
||
|
|
|
|||
|
|
||||
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|
||
CAYMAN ISLANDS |
|
|
|||
|
|
||||
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
|
5
|
SOLE VOTING POWER
|
|
|
|
0
|
|
|
|||
|
|
||||
6
|
SHARED VOTING POWER
|
|
|
||
587,464 (1)
|
|
|
|||
|
|
||||
7
|
SOLE DISPOSITIVE POWER
|
|
|
||
0
|
|
|
|||
|
|
||||
8
|
SHARED DISPOSITIVE POWER
|
|
|
||
587,464 (1)
|
|
|
|||
|
|
||||
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|
|
||
587,464 (1)
|
|
|
|||
|
|
||||
10
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
|
|
|
||
☐
|
|
|
|||
|
|
||||
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
|
|
|
||
5.1% (2) |
|
|
|||
|
|
||||
12
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
|
|
|
||
OO |
|
|
|||
|
|
|
(1) |
Includes 359,812 Shares obtainable upon exercise of Series A Warrants and 118,738 Shares obtainable upon exercise of Series B Warrants.
|
|
(2) |
This percentage is calculated based on the sum of (i) 11,040,600 Shares outstanding as of November 2, 2020 according to the Issuer’s Form 10-Q, filed on November 5, 2020, (ii) 359,812 Shares obtainable upon exercise
of Series A Warrants and (iii) 118,738 Shares obtainable upon conversion of Series B Warrants.
|
CUSIP No. 82640U107
|
Page 4 of 10
|
1
|
NAMES OF REPORTING PERSONS
|
|
|
||
NATHANIEL AUGUST
|
|
|
|||
|
|
||||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
||||
(a)☒
|
|||||
(b)☐
|
|
|
|||
3
|
SEC USE ONLY
|
|
|
||
|
|
|
|||
|
|
||||
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|
||
UNITED STATES OF AMERICA
|
|
|
|||
|
|
||||
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
|
5
|
SOLE VOTING POWER
|
|
|
|
0
|
|
|
|||
|
|
||||
6
|
SHARED VOTING POWER
|
|
|
||
587,464 (1)
|
|
|
|||
|
|
||||
7
|
SOLE DISPOSITIVE POWER
|
|
|
||
0
|
|
|
|||
|
|
||||
8
|
SHARED DISPOSITIVE POWER
|
|
|
||
587,464 (1)
|
|
|
|||
|
|
||||
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|
|
||
587,464 (1)
|
|
|
|||
|
|
||||
10
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
|
|
|
||
☐
|
|
|
|||
|
|
||||
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
|
|
|
||
5.1% (2)
|
|
|
|||
|
|
||||
12
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
|
|
|
||
IN, HC
|
|
|
|||
|
|
|
(1) |
Includes 359,812 Shares obtainable upon exercise of Series A Warrants and 118,738 Shares obtainable upon exercise of Series B Warrants.
|
|
(2) |
This percentage is calculated based on the sum of (i) 11,040,600 Shares outstanding as of November 2, 2020 according to the Issuer’s Form 10-Q, filed on November 5, 2020, (ii) 359,812 Shares obtainable upon exercise
of Series A Warrants and (iii) 118,738 Shares obtainable upon conversion of Series B Warrants.
|
CUSIP No. 82640U107
|
Page 5 of 10
|
Item 1(a). |
Name of Issuer:
|
Item 1(b). |
Address of Issuer’s Principal Executive Offices:
|
Item 2(a). |
Name of Person Filing
|
|
i) |
The Mangrove Partners Master Fund, Ltd. (the “Master Fund”);
|
|
ii) |
Mangrove Partners; and
|
|
iii) |
Nathaniel August (“Mr. August”)
|
Item 2(b). |
Address of Principal Business Office or, if None, Residence:
|
Item 2(c). |
Citizenship:
|
Item 2(d). |
Title of Class of Securities:
|
Item 2(e). |
CUSIP Number:
|
Item 3. |
If This Statement is Filed Pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), Check Whether the Person Filing is a:
|
CUSIP No. 82640U107
|
Page 6 of 10
|
Item 4. |
Ownership:
|
Item 4(a) |
Amount Beneficially Owned:
|
Item 4(b) |
Percent of Class:
|
Item 4(c) |
Number of Shares as to which such person has:
|
(i) Sole power to vote or direct the vote:
|
0
|
(ii) Shared power to vote or direct the vote:
|
587,464
|
(iii) Sole power to dispose or direct the disposition of:
|
0
|
(iv) Shared power to dispose or direct the disposition of:
|
587,464
|
Item 5. |
Ownership of Five Percent or Less of a Class:
|
Item 6. |
Ownership of More than Five Percent on Behalf of Another Person:
|
Item 7. |
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person:
|
Item 8. |
Identification and Classification of Members of the Group:
|
Item 9. |
Notice of Dissolution of Group:
|
CUSIP No. 82640U107
|
Page 7 of 10
|
Item 10.
|
Certification:
|
CUSIP No. 82640U107
|
Page 8 of 10
|
THE MANGROVE PARTNERS MASTER FUND, LTD.
|
|||
By:
|
Mangrove Partners Investment Manager
|
||
By:
|
/s/ Nathaniel H. August
|
||
Name: Nathaniel H. August
|
|||
Title: Director
|
|
MANGROVE PARTNERS
|
||
By:
|
/s/ Nathaniel H. August
|
||
Name: Nathaniel H. August
|
|||
Title: Director
|
NATHANIEL H. AUGUST
|
||
/s/ Nathaniel H. August
|
CUSIP No. 82640U107
|
Page 9 of 10
|
Ex.
|
Page No.
|
|
A
|
Joint Filing Agreement
|
10
|
CUSIP No. 82640U107
|
Page 10 of 10
|
THE MANGROVE PARTNERS MASTER FUND, LTD.
|
|||
By:
|
Mangrove Partners Investment Manager
|
||
By:
|
/s/ Nathaniel H. August
|
||
Name: Nathaniel H. August
|
|||
Title: Director
|
MANGROVE PARTNERS
|
|||
By:
|
/s/ Nathaniel H. August
|
||
Name: Nathaniel H. August
|
|||
Title: Director
|
NATHANIEL H. AUGUST
|
|||
/s/ Nathaniel H. August
|
1 Year Sierra Oncology Chart |
1 Month Sierra Oncology Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions